If you made any changes in Pure these will be visible here soon.

Research Output 2005 2018

  • 688 Citations
  • 11 h-Index
  • 24 Article
  • 1 Review article
2018

Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?

Bronte, G., Bravaccini, S., Ravaioli, S., Puccetti, M., Scarpi, E., Andreis, D., Tumedei, M. M., Sarti, S., Cecconetto, L., Pietri, E., De Simone, V., Maltoni, R., Bonafè, M., Amadori, D. & Rocca, A., Aug 1 2018, In : Translational Oncology. 11, 4, p. 950-956 7 p.

Research output: Contribution to journalArticle

Androgen Receptors
Breast Neoplasms
Neoplasm Metastasis
Neoplasms
Tumor Biomarkers

Androgen receptor in advanced breast cancer: Is it useful to predict the efficacy of anti-estrogen therapy?

Bronte, G., Rocca, A., Ravaioli, S., Puccetti, M., Tumedei, M. M., Scarpi, E., Andreis, D., Maltoni, R., Sarti, S., Cecconetto, L., Fedeli, A., Pietri, E., De Simone, V., Asioli, S., Bravaccini, S. & Amadori, D., Mar 27 2018, In : BMC Cancer. 18, 1, 348.

Research output: Contribution to journalArticle

Androgen Receptors
Estrogens
Breast Neoplasms
Progesterone Receptors
Estrogen Receptors

Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer

Pietri, E., Massa, I., Bravaccini, S., Ravaioli, S., Tumedei, M. M., Petracci, E., Donati, C., Schirone, A., Piacentini, F., Gianni, L., Nicolini, M., Campadelli, E., Gennari, A., Saba, A., Campi, B., Valmorri, L., Andreis, D., Fabbri, F., Amadori, D. & Rocca, A., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Dehydroepiandrosterone
Androgen Receptors
Breast Neoplasms
Estrogen Receptors
Aromatase Inhibitors

Quantification of dehydroepiandrosterone in human serum on a routine basis: development and validation of a tandem mass spectrometry method based on a surrogate analyte

Campi, B., Frascarelli, S., Pietri, E., Massa, I., Donati, C., Bozic, R., Bertelloni, S., Paolicchi, A., Zucchi, R. & Saba, A., 2018, In : Analytical and Bioanalytical Chemistry. 410, 2, p. 407-416 10 p.

Research output: Contribution to journalArticle

2017
Ductal Carcinoma
Androgen Receptors
Estrogen Receptors
Radiotherapy
Biomarkers

Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer

Rocca, A., Cecconetto, L., Passardi, A., Melegari, E., Andreis, D., Monti, M., Maltoni, R., Sarti, S., Pietri, E., Schirone, A., Fabbri, F., Donati, C., Nanni, O., Fedeli, A., Faedi, M. & Amadori, D., May 1 2017, In : Cancer Chemotherapy and Pharmacology. 79, 5, p. 863-871 9 p.

Research output: Contribution to journalArticle

Toxicity
Breast Neoplasms
Diarrhea
Hand-Foot Syndrome
Anthracyclines
2016

Androgen receptor signaling pathways as a target for breast cancer treatment

Pietri, E., Conteduca, V., Andreis, D., Massa, I., Melegari, E., Sarti, S., Cecconetto, L., Schirone, A., Bravaccini, S., Serra, P., Fedeli, A., Maltoni, R., Amadori, D., De Giorgi, U. & Rocca, A., Oct 1 2016, In : Endocrine-Related Cancer. 23, 10, p. R485-R498

Research output: Contribution to journalReview article

Androgen Receptors
Breast Neoplasms
Androgen Receptor Antagonists
Neoplasms
Triple Negative Breast Neoplasms
2015
Epirubicin
Paclitaxel
Fluorouracil
Cyclophosphamide
Breast Neoplasms

Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer

Rocca, A., Farolfi, A., Maltoni, R., Carretta, E., Melegari, E., Ferrario, C., Cecconetto, L., Sarti, S., Schirone, A., Fedeli, A., Andreis, D., Pietri, E., Ibrahim, T., Montalto, E. & Amadori, D., May 27 2015, In : Breast Cancer Research and Treatment. 152, 1, p. 57-65 9 p.

Research output: Contribution to journalArticle

Progesterone Receptors
Breast Neoplasms
Neoplasm Metastasis
Therapeutics
Neoplasms

Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy

Rocca, A., Andreis, D., Fedeli, A., Maltoni, R., Sarti, S., Cecconetto, L., Pietri, E., Schirone, A., Bravaccini, S., Serra, P., Farolfi, A. & Amadori, D., Oct 3 2015, In : Expert Opinion on Drug Metabolism and Toxicology. 11, 10, p. 1647-1663 17 p.

Research output: Contribution to journalArticle

Pharmacodynamics
Pharmacokinetics
Breast Neoplasms
docetaxel
Therapeutics

Uncovering the genomic heterogeneity of multifocal breast cancer

Desmedt, C., Fumagalli, D., Pietri, E., Zoppoli, G., Brown, D., Nik-Zainal, S., Gundem, G., Rothé, F., Majjaj, S., Garuti, A., Carminati, E., Loi, S., Van Brussel, T., Boeckx, B., Maetens, M., Mudie, L., Vincent, D., Kheddoumi, N., Serra, L., Massa, I. & 9 others, Ballestrero, A., Amadori, D., Salgado, R., De Wind, A., Lambrechts, D., Piccart, M., Larsimont, D., Campbell, P. J. & Sotiriou, C., Aug 1 2015, In : Journal of Pathology. 236, 4, p. 457-466 10 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Mutation
Genome
Molecular Targeted Therapy
Neoplasms
2013

Trastuzumab-induced cardiotoxicity in early breast cancer patients: A retrospective study of possible risk and protective factors

Farolfi, A., Melegari, E., Aquilina, M., Scarpi, E., Ibrahim, T., Maltoni, R., Sarti, S., Cecconetto, L., Pietri, E., Ferrario, C., Fedeli, A., Faedi, M., Nanni, O., Frassineti, G. L., Amadori, D. & Rocca, A., May 2013, In : Heart. 99, 9, p. 634-639 6 p.

Research output: Contribution to journalArticle

Retrospective Studies
Breast Neoplasms
Epirubicin
Medical Oncology
Trastuzumab
2012

Multicentric/multifocal breast cancer with a single histotype: Is the biological characterization of all individual FOCI justified?

Buggi, F., Folli, S., Curcio, A., Casadei-Giunchi, D., Rocca, A., Pietri, E., Medri, L. & Serra, L., Aug 2012, In : Annals of Oncology. 23, 8, p. 2042-2046 5 p., mdr570.

Research output: Contribution to journalArticle

Breast Neoplasms
Neoplasm Grading
Carcinoma
Progesterone Receptors
Estrogen Receptors
2011

Case histories: Breast cancer

Gennari, A., Pietri, E. & Amadori, D., Oct 2011, In : European Journal of Cancer, Supplement. 9, 2, p. 36-42 7 p.

Research output: Contribution to journalArticle

2010
Breast Neoplasms
Anthracyclines
Maximum Tolerated Dose
Epirubicin
Febrile Neutropenia
2009
Vascular Endothelial Growth Factor A
Breast Neoplasms
Serum
Disease-Free Survival
Perioperative Period
2008

Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer

Dellapasqua, S., Bertolini, F., Bagnardi, V., Campagnoli, E., Scarano, E., Torrisi, R., Shaked, Y., Mancuso, P., Goldhirsch, A., Rocca, A., Pietri, E. & Colleoni, M., Oct 20 2008, In : Journal of Clinical Oncology. 26, 30, p. 4899-4905 7 p.

Research output: Contribution to journalArticle

Cyclophosphamide
Breast Neoplasms
Endothelial Cells
Poisons
Capecitabine
Chemotherapy
Cisplatin
Breast Neoplasms
Drug Therapy
Anthracyclines
Type II DNA Topoisomerase
Anthracyclines
Breast Neoplasms
Drug Therapy
Genes
2006
Breast Neoplasms
Drug Therapy
Fluorouracil
Epirubicin
Progesterone Receptors

Factor V Leiden mutation in patients with breast cancer with a central venous catheter: Risk of deep vein thrombosis

Curigliano, G., Mandalà, M., Sbanotto, A., Colleoni, M., Ferretti, G., Bucciarelli, P., Peruzzotti, G., De Braud, F., De Pas, T., Spitaleri, G., Pietri, E., Orsi, F., Banfi, M. G. & Goldhirsch, A., Jan 2006, In : Supportive Cancer Therapy. 3, 2, p. 98-102 5 p.

Research output: Contribution to journalArticle

Central Venous Catheters
Venous Thrombosis
Breast Neoplasms
Mutation
Prothrombin
Methotrexate
Cyclophosphamide
Breast Neoplasms
Drug Therapy
Trastuzumab
2005
Fibroblast Growth Factor 2
Transforming Growth Factor beta
Vascular Endothelial Growth Factor A
Breast Neoplasms
Mastectomy